Rick Doblin

Rick Doblin

Up next

Thais Gibson

Thais Gibson is a counselor, speaker, and leader in the personal development field. She has a Ph.D. and is certified in 13 modalities, including Cognitive Behavioral Therapy, NLP, Somatic Processing, and Trauma Work. Her scientific research, personal experience, and compassionate ...  Show more

Gregg Braden

Gregg Braden is a five-time New York Times best-selling author, scientist, international educator and renowned as a pioneer in the emerging paradigm based in science, social policy and human potential. From 1979 to 1991 Gregg worked as a problem solver during times of crisis for ...  Show more

Recommended Episodes

The Journey of Psychedelics with Rick Doblin from MAPS
Gateways to Awakening

Today’s episode is with Rick Doblin Ph.D., the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of t ...  Show more

Rick Doblin
Flow Sessions with Jason Silva

Rick Doblin is the founder and executive director of the Multi-Disciplinary Association for Psychedelic Studies, MAPS. He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of ...  Show more

#63: The Psychedelic Renaissance - Rick Doblin, PhD
The FitMind Podcast: Mental Fitness, Neuroscience & Psychology

Dr. Rick Doblin is the Founder and Director of MAPS, which has raised over $100 million for supporting psychedelics research. Rick is one of the key leaders of this current psychedelic renaissance. He received a doctorate in public policy from Harvard's Kennedy School of Governme ...  Show more

#2319 - Rick Doblin
The Joe Rogan Experience

Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated Lykos Therapeutics (formerly MAPS Public Benefit ...  Show more